IL78248A - 5-(6-imidazo(1,2-a)pyridyl)pyridine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

5-(6-imidazo(1,2-a)pyridyl)pyridine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL78248A
IL78248A IL78248A IL7824886A IL78248A IL 78248 A IL78248 A IL 78248A IL 78248 A IL78248 A IL 78248A IL 7824886 A IL7824886 A IL 7824886A IL 78248 A IL78248 A IL 78248A
Authority
IL
Israel
Prior art keywords
sup
group
hydrogen atom
represents hydrogen
lower alkyl
Prior art date
Application number
IL78248A
Other languages
English (en)
Other versions
IL78248A0 (en
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of IL78248A0 publication Critical patent/IL78248A0/xx
Publication of IL78248A publication Critical patent/IL78248A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL78248A 1985-03-26 1986-03-24 5-(6-imidazo(1,2-a)pyridyl)pyridine derivatives,their preparation and pharmaceutical compositions containing them IL78248A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60059450A JPS61218589A (ja) 1985-03-26 1985-03-26 ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体

Publications (2)

Publication Number Publication Date
IL78248A0 IL78248A0 (en) 1986-07-31
IL78248A true IL78248A (en) 1989-09-10

Family

ID=13113637

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78248A IL78248A (en) 1985-03-26 1986-03-24 5-(6-imidazo(1,2-a)pyridyl)pyridine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (4) US4751227A (da)
EP (1) EP0199127B1 (da)
JP (1) JPS61218589A (da)
KR (1) KR930005005B1 (da)
CN (1) CN1020608C (da)
AT (1) ATE48603T1 (da)
AU (1) AU589410B2 (da)
CA (1) CA1309718C (da)
DD (2) DD283390A5 (da)
DE (1) DE3667466D1 (da)
DK (1) DK164788C (da)
ES (5) ES8706146A1 (da)
FI (1) FI86722C (da)
GR (1) GR860720B (da)
HU (1) HU198045B (da)
IE (1) IE59294B1 (da)
IL (1) IL78248A (da)
MX (1) MX163696B (da)
NO (1) NO163490C (da)
PH (1) PH22999A (da)
PT (1) PT82270B (da)
SU (1) SU1468420A3 (da)
ZA (1) ZA862259B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
WO1991000092A1 (en) * 1989-06-13 1991-01-10 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
SE9903611D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds III
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CN102781930B (zh) * 2009-12-18 2016-03-23 田边三菱制药株式会社 抗血小板药
CN101830900B (zh) * 2010-05-27 2012-06-06 齐鲁制药(海南)有限公司 盐酸奥普力农晶型及其制备方法
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012118972A2 (en) 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
CN102718747B (zh) * 2012-06-27 2014-06-11 武汉武药科技有限公司 盐酸奥普力农衍生物及其合成方法
CN102702197B (zh) * 2012-06-27 2014-12-03 武汉武药科技有限公司 盐酸奥普力农衍生物及其制备方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
CN105979959B (zh) 2013-08-09 2021-11-30 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
CN106349246B (zh) * 2016-08-29 2018-10-26 山东百诺医药股份有限公司 奥普力农及9-氮杂吲哚-5-硼酸的制备方法
CN108840866A (zh) * 2018-05-24 2018-11-20 河北宇辰医药科技有限公司 一种奥普力农类似物ⅰ的制备方法与用途
CN109575017A (zh) * 2018-11-01 2019-04-05 山东蒲济医药科技有限公司 一种盐酸奥普力农化合物的制备方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN111499631B (zh) * 2020-06-02 2021-07-30 济南康桥医药科技有限公司 一种盐酸奥普力农关键中间体1-咪唑并[1,2-a]吡啶-6-基-2-丙酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
PT82270A (en) 1986-04-01
AU589410B2 (en) 1989-10-12
ES8708231A1 (es) 1987-10-01
JPH0558437B2 (da) 1993-08-26
DK137786A (da) 1986-09-27
IE59294B1 (en) 1994-02-09
PH22999A (en) 1989-02-24
NO163490C (no) 1990-06-06
US4751227A (en) 1988-06-14
NO861190L (no) 1986-09-29
ZA862259B (en) 1986-11-26
CN86102812A (zh) 1986-11-26
CN1020608C (zh) 1993-05-12
ES8706146A1 (es) 1987-05-16
FI86722B (fi) 1992-06-30
DE3667466D1 (de) 1990-01-18
ES557236A0 (es) 1987-10-01
GR860720B (en) 1986-03-25
SU1468420A3 (ru) 1989-03-23
DK164788C (da) 1992-12-28
ES8801655A1 (es) 1988-02-16
IL78248A0 (en) 1986-07-31
ES8708230A1 (es) 1987-10-01
DK164788B (da) 1992-08-17
JPS61218589A (ja) 1986-09-29
US4803276A (en) 1989-02-07
HUT41026A (en) 1987-03-30
KR860007257A (ko) 1986-10-10
HU198045B (en) 1989-07-28
US4791203A (en) 1988-12-13
KR930005005B1 (ko) 1993-06-11
IE860775L (en) 1986-09-26
DD283390A5 (de) 1990-10-10
FI86722C (fi) 1992-10-12
FI861262A0 (fi) 1986-03-25
EP0199127B1 (en) 1989-12-13
DD263057A5 (de) 1988-12-21
PT82270B (pt) 1988-02-17
US4791202A (en) 1988-12-13
ES557587A0 (es) 1988-02-16
NO163490B (no) 1990-02-26
ES557588A0 (es) 1988-02-16
MX163696B (es) 1992-06-15
ES557235A0 (es) 1987-10-01
AU5507286A (en) 1986-10-02
ATE48603T1 (de) 1989-12-15
EP0199127A1 (en) 1986-10-29
ES8801654A1 (es) 1988-02-16
ES553370A0 (es) 1987-05-16
FI861262A (fi) 1986-09-27
CA1309718C (en) 1992-11-03
DK137786D0 (da) 1986-03-25

Similar Documents

Publication Publication Date Title
IL78248A (en) 5-(6-imidazo(1,2-a)pyridyl)pyridine derivatives,their preparation and pharmaceutical compositions containing them
DE3273019D1 (en) Pyrimidinone derivatives and pharmaceutical compositions containing them
EP0355169A4 (en) Antianxiety drug
EP0115920A3 (en) Pyrazino(2',3'-3,4)pyrido(1,2-a) indole derivatives
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees